Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,085 papers from all fields of science
Search
Sign In
Create Free Account
SDZ 280 446
Known as:
SDZ 280-446
, SDZ-280 446
, SDZ-280446
A novel semi-synthetic derivative of cyclosporin and a cyclodepsipeptide with chemo-sensitizing activity. SDZ 280-446 is one of the drug resistance…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
ABCB1 protein, human
Broader (1)
Cyclic Peptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1995
Highly Cited
1995
Decreased biotolerability for ivermectin and cyclosporin a in mice exposed to potent P‐glycoprotein inhibitors
A. Didier
,
F. Loor
International Journal of Cancer
1995
Corpus ID: 29279391
SDZ PSC 833 or SDZ 280‐446 are strong blockers of the function of class 1 mdr gene‐encoded P‐glycoprotein molecules, which were…
Expand
1994
1994
Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents.
D. Boesch
,
F. Loor
Anti-Cancer Drugs
1994
Corpus ID: 24910565
The low daunomycin (DAU) retention in P388 cells displaying P-glycoprotein (Pgp)-mediated multidrug resistance (MDR) can be…
Expand
1994
1994
Modulation of human P-glycoprotein epitope expression by temperature and/or resistance-modulating agents.
B. Jachez
,
M. Cianfriglia
,
F. Loor
Anti-Cancer Drugs
1994
Corpus ID: 23040706
Three monoclonal antibodies (mAb), MRK16, MM4.17 and MC57, directed against distinct epitopes on the external domain of human P…
Expand
Highly Cited
1993
Highly Cited
1993
Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446.
B. Jachez
,
R. Nordmann
,
F. Loor
Journal of the National Cancer Institute
1993
Corpus ID: 8974924
BACKGROUND Taxol, a promising agent for the treatment of cancer, has entered phase II clinical trials. Nevertheless, it belongs…
Expand
1993
1993
Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
B. Jachez
,
F. Loor
Anti-Cancer Drugs
1993
Corpus ID: 25912258
Verapamil, cyclosporin A (CsA), the cyclosporin derivative SDZ PSC 833 and the novel cyclopeptolide SDZ 280-446 were tested for…
Expand
1992
1992
SDZ PSC 833 and SDZ 280–446 are the most active of various resistance‐modifying agents in restoring rhodamine‐123 retention within multidrug resistant P388 cells
A. Pourtier-Manzanedo
,
A. Didier
,
C. Muller
,
F. Loor
Anti-Cancer Drugs
1992
Corpus ID: 21908617
Multidrug resistance (MDR) of tumor cells may result from overexpression of P-glycoprotein (Pgp) but may be down-modulated by…
Expand
1992
1992
Expression of P-glycoprotein on normal lymphocytes: enhancement of the doxorubicin-sensitivity of concanavalin A-responding mouse spleen cells by P-glycoprotein blockers.
A. Pourtier-Manzanedo
,
A. Didier
,
F. Loor
Oncology Research
1992
Corpus ID: 26024865
The in vitro proliferative response of mouse spleen cells (SC) to the T-cell mitogen, concanavalin A (ConA), displays a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE